Implementation and evaluation of a nurse-enabled, shared-care follow-up model for early breast cancer survivors on health-related quality of life (The IBIS-Survivorship Study)

Professor Raymond Chan0 sites1,358 target enrollmentFebruary 22, 2021

Overview

No summary available.

Registry

who.int

Start Date

February 22, 2021

End Date

TBD

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Sponsor

Professor Raymond Chan

•Early breast cancer as defined as stage I\-III (inclusive of ductal carcinoma in situ (DCIS) and locally advanced breast cancer but no distant metastases) who are:
•\- within ten weeks of completion of adjuvant treatment for early stage breast cancer at a participating site; OR within ten weeks post\-surgery if not scheduled for further adjuvant therapy;
•\- Can identify a regular GP;
•\- Ambulatory with Eastern Cooperative Oncology Group (ECOG) performance status of 0\-2; and
•\- Able to read and understand English.
•Recurrent or secondary primary breast cancer, comorbidities, other prior cancer diagnoses or Trastuzumab (or biosimilars), neoadjuvant and/or ongoing endocrine therapies are NOT exclusion criteria

•\- have metastatic (distant) breast cancer; or
•\- the presence of severe mental, cognitive or physical conditions that would limit the patient’s ability to participate at the discretion of treating clinicians